ArticleCNS drugs2023

Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study.

Meredith Castro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.